FMS
Fresenius Medical Care AG & Co. KGaA
There isn't enough reported data to score FMS yet.
UNH
UnitedHealth Group Incorporated
UNH's fundamentals are mixed: free cash flow grew 31%, but earnings per share fell 8.5%. At 23x earnings, it's trading right at its usual valuation. Analysts expect strong earnings growth, though they disagree widely on how much.
FMS Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Strong | |
| Strong | |
| Stable |
FMS's profitability and cash flow are currently strong, and its balance sheet is stable. There isn't enough data to rate its revenue.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
FMS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $38.09 | +76% |
| Fair | 12x | $40.06 | +85% |
| Current | 13x | $21.60 | — |
| Expensive | 16x | $51.64 | +139% |
Historical ranges are pointers, not guarantees.
FMS has the edge over UNH in the historical PE scenario, which offers more potential upside but is not a forecast.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
FMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Stable | |
| Stable | |
| Limited | |
| Low |
Analysts expect FMS's earnings, revenue and profitability to hold roughly steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
UNH has the edge over FMS on the outlook, with more favorable earnings and profitability expectations.
FMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $3.30 | +21% |
| Q4 2025 | $3.73 | +84% |
| Q3 2025 | $2.72 | +8.8% |
| Q2 2025 | $2.49 | +24% |
| Q1 2025 | $2.34 | +28% |
| Q4 2024 | $2.03 | +7.4% |
| Q3 2024 | $2.50 | +46% |
| Q2 2024 | $2.01 | -11% |
FMS has the stronger earnings trend. Trailing diluted EPS is up 41% for FMS versus UNH down 8.5%.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH's earnings per share have fallen from their peak: $17.55 over the past year, against $23.89 in early 2025.
FMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $16B | +195% |
| Q4 2025 | $5.6B | -0.3% |
| Q3 2025 | $5.4B | +2.6% |
| Q2 2025 | $5.3B | +0.5% |
| Q1 2025 | $5.4B | +3.3% |
| Q4 2024 | $5.6B | +1.9% |
| Q3 2024 | $5.3B | -3.6% |
| Q2 2024 | $5.3B | -1.2% |
FMS has the stronger quarterly revenue trend. Revenue is up 195% for FMS versus down 0.4% for UNH.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.9% | +1.1 points |
| Q4 2025 | 12% | +6.6 points |
| Q3 2025 | 9.8% | 0 points |
| Q2 2025 | 8.9% | 0 points |
| Q1 2025 | 6.8% | +1.6 points |
| Q4 2024 | 5.1% | -3.5 points |
| Q3 2024 | 9.7% | +3.2 points |
| Q2 2024 | 8.9% | +1.5 points |
FMS has the edge over UNH on profitability, with a higher operating margin.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH's operating margin was 5.8% last quarter, up 2 points from the same quarter a year ago.
FMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2020 | $555.7M | +$1B |
| Q2 2020 | $2.3B | +278% |
FMS and UNH do not have enough comparable growth data to identify a winner.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH still generates free cash flow, though less than at its 2022 peak: $22.8B over the past year.
FMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -7.7% | -22.4M shares |
| 1 year | -8.4% | -24.6M shares |
| 3 years | -8.4% | -24.6M shares |
| 5 years | -8.2% | -24M shares |
| Available history | -11% | -34.6M shares |
FMS has the edge over UNH on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $862.2M |
| Q4 2025 | $482.3M |
| Q4 2020 | — |
| Q3 2020 | — |
| Q2 2020 | $166.5M |
| Q1 2020 | $240.1M |
| Q4 2019 | $150.3M |
| Q3 2019 | $848.1M |
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has 902M diluted shares, down 0.7% from a year ago, with $5B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
FMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.9x | Healthy |
| Q4 2025 | 2.8x | Moderate |
| Q3 2025 | 1.9x | Healthy |
| Q2 2025 | 1.9x | Healthy |
| Q1 2025 | 1.9x | Healthy |
| Q4 2024 | 3.4x | Elevated |
| Q3 2024 | 1.9x | Healthy |
| Q2 2024 | 2.1x | Moderate |
FMS's net debt is about 1.9 years of its operating earnings (EBITDA), about the same as a year ago.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH has the edge over FMS on leverage, with a lower net debt burden relative to earnings.
FMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 42.8 | Neutral |
| Stochastic | 39.7 | Neutral |
FMS's weekly RSI is 43 (neutral) and its Stochastic is 40 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
FMS PE vs Healthcare Sector
| Metric | FMS | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 26x | 49% below |
| PE % | 69 | 29 | 40 pts above |
FMS has the edge over UNH on valuation relative to its sector.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
FMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $22.3 | 3.1% below |
| 20 week MA | $23.1 | 6.5% below |
| 50 week MA | $23.0 | 6% below |
| 100 week MA | $24.2 | 11% below |
| 200 week MA | $22.6 | 4.3% below |
FMS is in a downtrend: it's below all five of its weekly moving averages, and 4.3% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over FMS on trend strength, trading above more of its moving averages.
FMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $37.4 | $41.3 | +10% |
| 2021 | $41.3 | $32.1 | -22% |
| 2022 | $32.1 | $16.0 | -50% |
| 2023 | $16.0 | $20.8 | +30% |
| 2024 | $20.8 | $23.0 | +10% |
| 2025 | $23.0 | $24.1 | +5% |
| 2026 YTD | $24.1 | $21.6 | -10% |
FMS has finished higher in four of the last six years. It's down 10% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over FMS on returns for 2026, with the stronger performance.